Clinical Trial Update: Safety Study of Cenderitide in Stable Chronic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 safety study of cenderitide in stable chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cenderitide (CD-NP)

Snippet

Sponsor: Capricor Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED